These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 35344128
1. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar. Donko A, Kuhns DB, Cousin MA, Smith MJ, Sacco KA, Klee EW, Joshi AY, Gavrilova RH, Holland SM, Leto TL, Abraham RS. J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128 [Abstract] [Full Text] [Related]
2. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. Jirapongsananuruk O, Malech HL, Kuhns DB, Niemela JE, Brown MR, Anderson-Cohen M, Fleisher TA. J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359 [Abstract] [Full Text] [Related]
3. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort. Baris HE, Ogulur I, Akcam B, Kiykim A, Karagoz D, Saraymen B, Akgun G, Eltan SB, Aydemir S, Akidagi Z, Bentli E, Nain E, Kasap N, Baser D, Altintas DU, Camcioglu Y, Yesil G, Ozen A, Koker MY, Karakoc-Aydiner E, Baris S. J Allergy Clin Immunol Pract; 2020 Feb; 8(10):3525-3534.e1. PubMed ID: 32736065 [Abstract] [Full Text] [Related]
4. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, Metin A, de Boer M, Avcılar H, Patıroğlu T, Yıldıran A, Yeğin O, Tezcan I, Sanal Ö, Roos D. J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690 [Abstract] [Full Text] [Related]
5. NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease. Sacco KA, Smith MJ, Bahna SL, Buchbinder D, Burkhardt J, Cooper MA, Hartog NL, Kobrynski L, Patel KP, Abraham RS. J Clin Immunol; 2020 Jan; 40(1):191-202. PubMed ID: 31813112 [Abstract] [Full Text] [Related]
6. Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience. El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, Elaziz DA, Freiberger T, Ravcukova B, Litzman J, Bustamante J, Boutros J, Gaafar T, Elmarsafy A. J Clin Immunol; 2016 Aug; 36(6):610-8. PubMed ID: 27222152 [Abstract] [Full Text] [Related]
7. Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients. Kulkarni M, Hule G, de Boer M, van Leeuwen K, Kambli P, Aluri J, Gupta M, Dalvi A, Mhatre S, Taur P, Desai M, Madkaikar M. J Clin Immunol; 2018 Nov; 38(8):898-916. PubMed ID: 30470980 [Abstract] [Full Text] [Related]
8. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation. Kim HY, Kim HJ, Ki CS, Kim DW, Yoo KH, Kang ES. Ann Lab Med; 2013 Jul; 33(4):288-92. PubMed ID: 23826567 [Abstract] [Full Text] [Related]
10. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease. Kaneda M, Sakuraba H, Ohtake A, Nishida A, Kiryu C, Kakinuma K. Blood; 1999 Mar 15; 93(6):2098-104. PubMed ID: 10068684 [Abstract] [Full Text] [Related]
11. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease. Badalzadeh M, Tajik S, Fazlollahi MR, Houshmand M, Fattahi F, Alizadeh Z, Movahedi M, Adab Z, Khotaei GT, Hamidieh AA, Heidarnazhad H, Pourpak Z. Int J Immunogenet; 2017 Dec 15; 44(6):314-321. PubMed ID: 28941186 [Abstract] [Full Text] [Related]
13. Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort. Sun B, Zhu Z, Hui X, Sun J, Wang W, Ying W, Zhou Q, Yao H, Hou J, Wang X. J Clin Immunol; 2022 Oct 15; 42(7):1564-1579. PubMed ID: 35796921 [Abstract] [Full Text] [Related]
14. Molecular basis of autosomal recessive chronic granulomatous disease in iran. Teimourian S, de Boer M, Roos D. J Clin Immunol; 2010 Jul 15; 30(4):587-92. PubMed ID: 20407811 [Abstract] [Full Text] [Related]
15. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A). Wolach B, Gavrieli R, de Boer M, van Leeuwen K, Wolach O, Grisaru-Soen G, Broides A, Etzioni A, Somech R, Roos D. J Clin Immunol; 2018 Feb 15; 38(2):193-203. PubMed ID: 29411231 [Abstract] [Full Text] [Related]
17. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients. Gul I, Khan TA, Akbar NU, Gul N, Ali R, Khan SN. Ital J Pediatr; 2023 Aug 02; 49(1):95. PubMed ID: 37533075 [Abstract] [Full Text] [Related]
18. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease. Aygun D, Koker MY, Nepesov S, Koker N, van Leeuwen K, de Boer M, Kıykım A, Ozsoy S, Cokugras H, Kuijpers T, Roos D, Camcıoglu Y. Int Arch Allergy Immunol; 2020 Aug 02; 181(7):540-550. PubMed ID: 32512560 [Abstract] [Full Text] [Related]